Wells Fargo & Company Increases Nutrien (NYSE:NTR) Price Target to $53.00

Nutrien (NYSE:NTR) had its target price increased by equities researchers at Wells Fargo & Company from $52.00 to $53.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target points to a potential upside of 0.83% from the stock’s previous close.

Other equities research analysts have also issued reports about the company. Barclays restated an “equal weight” rating and set a $56.00 price target (up from $55.00) on shares of Nutrien in a research report on Tuesday, January 21st. Raymond James raised Nutrien from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $58.00 to $60.00 in a report on Tuesday, December 3rd. Oppenheimer assumed coverage on Nutrien in a report on Thursday, December 12th. They issued an “outperform” rating and a $60.00 target price on the stock. TD Securities decreased their price target on Nutrien from $63.00 to $61.00 and set a “buy” rating for the company in a research note on Tuesday, November 12th. Finally, CIBC restated an “outperformer” rating and issued a $55.00 price target (down previously from $60.00) on shares of Nutrien in a research note on Tuesday, December 10th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have given a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $58.83.

Nutrien Trading Down 0.4 %

NYSE NTR opened at $52.57 on Tuesday. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. Nutrien has a twelve month low of $43.69 and a twelve month high of $60.87. The firm has a market capitalization of $25.81 billion, a PE ratio of 35.28, a P/E/G ratio of 1.17 and a beta of 0.81. The stock’s 50 day moving average is $47.61 and its 200 day moving average is $47.98.

Nutrien (NYSE:NTR) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.39 earnings per share for the quarter, missing the consensus estimate of $0.43 by ($0.04). Nutrien had a net margin of 2.79% and a return on equity of 6.99%. The firm had revenue of $5.35 billion for the quarter, compared to the consensus estimate of $5.26 billion. During the same quarter in the prior year, the firm earned $0.35 earnings per share. The company’s revenue for the quarter was down 5.0% compared to the same quarter last year. Research analysts forecast that Nutrien will post 3.5 earnings per share for the current fiscal year.

Institutional Trading of Nutrien

A number of large investors have recently made changes to their positions in the business. Central Pacific Bank Trust Division purchased a new position in shares of Nutrien during the 3rd quarter worth about $28,000. HHM Wealth Advisors LLC boosted its stake in shares of Nutrien by 331.0% during the 4th quarter. HHM Wealth Advisors LLC now owns 625 shares of the company’s stock worth $28,000 after purchasing an additional 480 shares during the period. Exchange Traded Concepts LLC boosted its position in Nutrien by 96.7% in the 4th quarter. Exchange Traded Concepts LLC now owns 846 shares of the company’s stock valued at $38,000 after buying an additional 416 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Nutrien in the 2nd quarter valued at about $52,000. Finally, Union Bancaire Privee UBP SA purchased a new stake in Nutrien in the 4th quarter valued at about $67,000. 63.10% of the stock is currently owned by institutional investors.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.